Design Therapeutics

United States
Solana Beach, California, United States, 92011

Company profile

Design Therapeutics company profile

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2017-01-01

Headquarters

Postal code
92011
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$170.5M
Last funding
Series B / $125M / 2021-01-27
Last equity funding
Series B / $125M
Investors
14
Lead investors
3
Founders
2
Articles
74
Exited on
2021-03-26

Founders and investors

Founders

Aseem AnsariPratik Shah

Lead investors

Logos CapitalNational Science FoundationSR One

Investors

BlackRockCormorant Asset ManagementRA Capital ManagementVivo CapitalWellington Management